PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-477 Cr | ₹-434 Cr | ₹-1,339 Cr | ₹-1,812 Cr | ₹-4,480 Cr |
What is the latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-477 Cr |
| Mar2024 | ₹-434 Cr |
| Mar2023 | ₹-1,339 Cr |
| Mar2022 | ₹-1,812 Cr |
| Mar2021 | ₹-4,480 Cr |
How is Cash Flow from Investing Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-477 Cr | Negative | |
| Mar2024 | ₹-434 Cr | Negative | |
| Mar2023 | ₹-1,339 Cr | Negative | |
| Mar2022 | ₹-1,812 Cr | Negative | |
| Mar2021 | ₹-4,480 Cr | - | |
Compare Cash Flow from Investing Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹19,771.9 Cr | 1.5% | 7.3% | -32.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,209.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,750.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,746.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,851.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| CIPLA | ₹99,268.4 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 1.5% |
7.3% |
-32.2% |
| SENSEX | 1.3% |
5.3% |
6.3% |
You may also like the below Video Courses